Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$5.17M
129.89K shares
What this filing means
KNIGHT JEFF E. plans to sell 129.89K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $5.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001950047-26-003982
Officer· Chief Operating Officer
Since Aug 2021
129.89K
Shares to sell
$5.17M
Approx. market value
9.48K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
5/4/2026
8.98KRestricted Stock Units
N/A
3/15/2025
500.00Total acquired9.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Exercise of Stock Options Cash | 8.98K | — |
3/15/2025 | Restricted Stock Units N/A | 500.00 | — |
| Total | 9.48K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
20.90K
Market value
$839.1K
4/14/2026
—Completed
Units to sell
4.43K
Market value
$177.4K
4/13/2026
—Completed
Units to sell
85.16K
Market value
$3.41M
4/8/2026
—Completed
Units to sell
9.91K
Market value
$370.4K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.48K
Market value
$370.1K
5/4/2026
Total
Units
129.89K
Value
$5.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 20.90K | $839.1K | — | Completed |
4/13/2026 | 4.43K | $177.4K | — | Completed |
4/8/2026 | 85.16K | $3.41M | — | Completed |
3/16/2026 | 9.91K | $370.4K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 9.48K | $370.1K | NASDAQ | Planned |
| Total | 129.89K | $5.17M | ||